NCT05311228View on ClinicalTrials.gov

The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

April 1, 2022

Conditions
Bronchopulmonary DysplasiaIntraventricular HemorrhageNecrotizing Enterocolitis
Interventions
DRUG

Azithromycin Powder

Azithromicyn intravena for 14 days

Trial Locations (1)

Unknown

University of Indonesia, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER